JL Laï

682 total citations
12 papers, 525 citations indexed

About

JL Laï is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, JL Laï has authored 12 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in JL Laï's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). JL Laï is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Acute Lymphoblastic Leukemia research (4 papers). JL Laï collaborates with scholars based in France, China and Belgium. JL Laï's co-authors include Marc Zandecki, M Flactif, Pierre Fenaux, Claude Preudhomme, Bernard Grandchamp, Franck Bernardi, Pierre Morel, F Bauters, J.P. Jouet and Thierry Façon and has published in prestigious journals such as Blood, Leukemia and Biochemical Genetics.

In The Last Decade

JL Laï

10 papers receiving 509 citations

Peers

JL Laï
Comparison fields: 5 of 48
  • Hematology 417
  • Molecular Biology 232
  • Genetics 162
  • Oncology 104
  • Public Health, Environmental and Occupational Health 102
Replace Ana Aventín with:
Ana Aventín Spain
MM Le Beau United States
M Flactif France
S. Patil United States
G.W. Dewald United States
C. Fonatsch Germany
Jastinder Sohal United Kingdom
Hendrati Pirc‐Danoewinata Austria
Patrik Andreasson Sweden
Dominique Mühlematter Switzerland
Ana Aventín Spain View profile →
Citations per field, relative to JL Laï
JL Laï · 1×
Citations per year, relative to JL Laï
JL Laï · 1×

Countries citing papers authored by JL Laï

Since Specialization
Citations

This map shows the geographic impact of JL Laï's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JL Laï with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JL Laï more than expected).

Fields of papers citing papers by JL Laï

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by JL Laï. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JL Laï. The network helps show where JL Laï may publish in the future.

Co-authorship network of co-authors of JL Laï

This figure shows the co-authorship network connecting the top 25 collaborators of JL Laï. A scholar is included among the top collaborators of JL Laï based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with JL Laï. JL Laï is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
# Work Indexed citations
1 1
2 0
3 2
4 0
5
Prospective, karyotype analysis in adult acute lymphoblastic leukemia: A LALA group (French-Belgium-Switzerland) report of 730 cases
2
6 84
7 185
8
Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations.
141
9
Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction.
86
10
Cytogenetic studies in 30 patients with Burkitt's lymphoma or L3 acute lymphoblastic leukemia with special reference to additional chromosome abnormalities.
21
11
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
2
12
[Karyotype of peripheral blood lymphocytes in patients treated for Hodgkin disease].
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026